Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BRKR Bruker Corp
- Stocks
- Healthcare
- NASDAQ: BRKR
Price (delayed)
$37.83
Market cap
$5.73B
P/E Ratio
72.75
Dividend/share
$0.2
EPS
$0.52
Enterprise value
$7.66B
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions
Highlights
BRKR's equity is up by 30% YoY
Bruker's revenue has increased by 15% YoY and by 2.4% QoQ
BRKR's EPS has dropped by 81% year-on-year and by 32% since the previous quarter
The net income has dropped by 80% year-on-year and by 30% since the previous quarter
Key stats
What are the main financial stats of BRKR
Market
Valuations
Earnings
Shares outstanding
151.53M
Market cap
$5.73B
Enterprise value
$7.66B
Price to earnings (P/E)
72.75
Price to book (P/B)
3.13
Price to sales (P/S)
1.66
EV/EBIT
47.92
EV/EBITDA
21.32
EV/Sales
2.22
Revenue
$3.45B
Gross profit
$1.69B
Operating income
$220.1M
Net income
$79.6M
EBIT
$159.9M
EBITDA
$359.4M
Free cash flow
$175.2M
Per share
Balance sheet
Liquidity
EPS
$0.52
EPS diluted
$0.52
Free cash flow per share
$1.16
Book value per share
$12.08
Revenue per share
$22.73
TBVPS
$23.08
Total assets
$5.93B
Total liabilities
$4.1B
Debt
$2.11B
Equity
$1.83B
Working capital
$766.6M
Debt to equity
1.15
Current ratio
1.57
Quick ratio
0.54
Net debt/EBITDA
5.37
Margins
Efficiency
Dividend
EBITDA margin
10.4%
Gross margin
49%
Net margin
2.3%
Operating margin
6.4%
Return on assets
1.3%
Return on equity
4.4%
Return on invested capital
3.8%
Return on capital employed
3.5%
Return on sales
4.6%
Dividend yield
0.53%
DPS
$0.2
Payout ratio
38.5%
BRKR stock price
How has the Bruker stock price performed over time
Intraday
1.15%
1 week
2.33%
1 month
-6.45%
1 year
-40.59%
YTD
-35.47%
QTD
-9.37%
Financial performance
How have Bruker's revenue and profit performed over time
Revenue
$3.45B
Gross profit
$1.69B
Operating income
$220.1M
Net income
$79.6M
Gross margin
49%
Net margin
2.3%
Bruker's net margin has plunged by 83% YoY and by 32% from the previous quarter
The net income has dropped by 80% year-on-year and by 30% since the previous quarter
BRKR's operating margin is down by 49% YoY and by 15% QoQ
BRKR's operating income is down by 42% year-on-year and by 13% since the previous quarter
Price vs fundamentals
How does BRKR's price correlate with its fundamentals
Growth
What is Bruker's growth rate over time
Valuation
What is Bruker stock price valuation
P/E
72.75
P/B
3.13
P/S
1.66
EV/EBIT
47.92
EV/EBITDA
21.32
EV/Sales
2.22
BRKR's EPS has dropped by 81% year-on-year and by 32% since the previous quarter
BRKR's price to earnings (P/E) is 76% higher than its 5-year quarterly average of 41.3 and 34% higher than its last 4 quarters average of 54.3
The stock's price to book (P/B) is 62% less than its 5-year quarterly average of 8.3 and 35% less than its last 4 quarters average of 4.8
BRKR's equity is up by 30% YoY
The stock's price to sales (P/S) is 56% less than its 5-year quarterly average of 3.8 and 39% less than its last 4 quarters average of 2.7
Bruker's revenue has increased by 15% YoY and by 2.4% QoQ
Efficiency
How efficient is Bruker business performance
BRKR's return on assets has dropped by 87% year-on-year and by 35% since the previous quarter
Bruker's return on equity has shrunk by 86% YoY and by 33% QoQ
Bruker's return on invested capital has shrunk by 78% YoY and by 25% QoQ
BRKR's return on sales has dropped by 73% year-on-year and by 25% since the previous quarter
Dividends
What is BRKR's dividend history
DPS
$0.2
Dividend yield
0.53%
Payout ratio
38.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Bruker financials performed over time
BRKR's total assets is 45% greater than its total liabilities
BRKR's total liabilities is up by 34% YoY and by 2.3% QoQ
BRKR's total assets is up by 32% year-on-year and by 2.2% since the previous quarter
Bruker's debt is 15% more than its equity
Bruker's debt has increased by 44% YoY
BRKR's equity is up by 30% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.